Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapyUri Kopylov, David Drobne, Darragh Storan et al.|Alimentary Pharmacology & Therapeutics|2020Cited by 80